Guangdong Yi Fang Pharmaceutical

Guangdong Yi Fang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and industrial production of Traditional Chinese Medicine (TCM) formula granules. Established in 1992, the company was a pioneer in the modernization of herbal medicine, becoming one of the first enterprises approved by the State Administration of Traditional Chinese Medicine for the industrialization of TCM granules. It operates as a core subsidiary of China Traditional Chinese Medicine Holdings, which is part of the state-owned Sinopharm Group. Yi Fang Pharmaceutical maintains a vast portfolio of over 700 standardized herbal granules, utilizing advanced quality control technologies such as fingerprint chromatography to ensure consistency and efficacy. The company's products are widely utilized in hospitals across China and are exported to international markets, positioning it as a dominant player in the global TCM industry.